🩺🩸Only 60% of South American centers use the international patient transfer tool ( #CIBMTR ), essential for post–stem cell transplantation follow-up. Low adherence may compromise data quality and clinical surveillance.
doi.org/10.46765/267...

#stemcelltransplantation #oncology #celltherapy

This study evaluated whether donor leukocyte telomere length, in conjunction with donor age, refines donor selection strategies to improve outcomes in recipients with acute leukemia.
doi.org/10.1016/j.xi...
#medicine #AcuteLeukemia #stemcelltransplantation

Long-term follow-up of dual CD19/CD22 CAR-T-cell therapy, as #Monotherapy and with autologous #StemCellTransplantation, in TP53-altered relapsed/refractory B-cell non-#HodgkinLymphoma patients, reveals clinical benefit & manageable toxicity.

#OpenAccess: doi.org/10.1038/s413...

💡 In a new Nature article, Drs. Gabriele Casirati, Andrea Cosentino, & the Genovese Lab at @danafarber.bsky.social described an alternative to chemotherapy and radiation conditioning to enable hematopoietic #StemCellTransplantation.

Learn more in our Q&A with the authors: https://bit.ly/4hDFjs1

Sometimes hope starts with the first word. I'm living with a rare disease and sharing my journey through #stemcelltransplantation in a blog - honest, brave,hopeful.Every #retweet helps create visibility. #RareDiseases #SezarySyndrome #Lymphoma #retweet
Vitaextra.ch

Individualized decitabine dosing for post-HSCT maintenance in MDS and secondary AML from MDS: long-term outcomes from the PODAC trial and matched controls

Therapeutic Advances in Hematology
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#stemcelltransplantation #cancer #oncology